|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Nuchal IIFrom: Y.A. Jones RDMS (yjones6149@aol.com)Sat Jan 23 07:57:25 1999
At Fri, 8 Jan 1999, art fougner, md wrote: > >Hot off the Presses!!! > >http://www.bmj.com/cgi/content/full/318/7176/81 > >basically, nuchal translucency screening also picks up about 50% of >fetuses with congenital heart disease. Have a look! > >Art > >-- >art fougner, md >SonoScan/Genetic Sciences >forest hills, ny >evsono@pipeline.com > We are currently using a cut off of 5mm to definitively sugest genetic testing. However, we had a case of .4mm at 12 weeks, she was ama, and proceded with amniocentesis only for dx of ama, + trisomy 21. What ar the current standards for risk per mm of increase, septations, age, etc.? Are you aware of any standards published. We don't wish to miss anything obviously, but nor do we care to overly alarm our mothers and subject them to invasive testing when the odds are low.
|
|
Return to
|
Mail a New Message to the Forum: ultrasound@obgyn.net Forum Administrator: terry.dubose@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:39:38 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.